Literature DB >> 16487231

Initial phase of chronic medication use; patients' reasons for discontinuation.

J G Hugtenburg1, A Th G Blom, S U Kisoensingh.   

Abstract

AIM: The aim of this study was to gain more insight into patients' reasons for discontinuing chronic medication.
METHODS: Electronic medication overviews recorded by a pharmacy were analysed with respect to patients' return behaviour during 3 months following their first prescription. Patients who did not return in time were interviewed by telephone to find out their reasons for either returning too late or not returning at all to the pharmacy to collect their repeat medication.
RESULTS: Of 232 first-time chronic medication prescriptions, 132 were not collected at all (46.1%) or too late (11%). These prescriptions involved 121 patients, 113 (93.4%) of whom participated in the telephone interview. Twenty patients returned too late to collect their repeat prescriptions, largely because they had forgotten to take their medication according to schedule (n=13). Ninety-three patients did not return to the pharmacy at all because of side-effects (24.5%), inefficacy (16.4%), medication not intended for chronic use (15.3%) and absence of need for continued use (14.3%).
CONCLUSIONS: About 50% of patients who have been prescribed chronic medication for the first time stop using their drugs within a matter of months. Perceived drug side-effects, drug ineffectiveness and personal considerations related to use and a lack of need of treatment were the main reasons for discontinuing chronic drug therapy. This kind of noncompliance may result in an increased health risk as well as constituting a waste of a large amount of money. Adequate patient counselling and shared decision-making between doctors and patients are needed to prevent the unnecessary cessation of chronic drug therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16487231      PMCID: PMC1885021          DOI: 10.1111/j.1365-2125.2005.02569.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

Review 1.  Enhancing drug compliance in lipid-lowering treatment.

Authors:  J H LaRosa; J C LaRosa
Journal:  Arch Fam Med       Date:  2000 Nov-Dec

Review 2.  Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

Authors:  K A Payne; S Esmonde-White
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

3.  Prescribing and taking medicines.

Authors:  Giselle Jones
Journal:  BMJ       Date:  2003-10-11

Review 4.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

Review 5.  Compliance and persistence with newer antihypertensive agents.

Authors:  William C Gerth
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

Review 6.  Interventions to enhance patient adherence to medication prescriptions: scientific review.

Authors:  Heather P McDonald; Amit X Garg; R Brian Haynes
Journal:  JAMA       Date:  2002-12-11       Impact factor: 56.272

7.  Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events.

Authors:  K Demyttenaere; P Enzlin; W Dewé; B Boulanger; J De Bie; W De Troyer; P Mesters
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

Review 8.  The direct effects of compliance on health outcome.

Authors:  L H Epstein
Journal:  Health Psychol       Date:  1984       Impact factor: 4.267

9.  Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research.

Authors:  M Robin DiMatteo
Journal:  Med Care       Date:  2004-03       Impact factor: 2.983

10.  Single use of sumatriptan: a patient interview study.

Authors:  H Rahimtoola; H Buurma; C C Tijssen; H G Leufkens; A C G Egberts
Journal:  Headache       Date:  2003-02       Impact factor: 5.887

View more
  10 in total

1.  Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003.

Authors:  Paola Deambrosis; Cristina Saramin; Gianni Terrazzani; Luca Scaldaferri; Patrizia Debetto; Pietro Giusti; Alessandro Chinellato
Journal:  Eur J Clin Pharmacol       Date:  2007-01-03       Impact factor: 2.953

2.  Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage.

Authors:  Elisabetta Poluzzi; Petar Strahinja; Alberto Vaccheri; Antonio Vargiu; Maria Chiara Silvani; Domenico Motola; Giulio Marchesini; Fabrizio De Ponti; Nicola Montanaro
Journal:  Br J Clin Pharmacol       Date:  2006-11-10       Impact factor: 4.335

Review 3.  Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care.

Authors:  Marc Cohen
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

4.  Investigating unused medications in New Zealand.

Authors:  Rhiannon Braund; Gregory Gn; Robynne Matthews
Journal:  Pharm World Sci       Date:  2009-08-26

5.  Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy.

Authors:  Prem Adhien; Liset van Dijk; Marinke de Vegter; Marnix Westein; Giel Nijpels; Jacqueline G Hugtenburg
Journal:  Int J Clin Pharm       Date:  2013-08-13

6.  Adherence to chronic medication in older populations: application of a common protocol among three European cohorts.

Authors:  Enrica Menditto; Caitriona Cahir; Mercedes Aza-Pascual-Salcedo; Dario Bruzzese; Beatriz Poblador-Plou; Sara Malo; Elisio Costa; Francisca González-Rubio; Antonio Gimeno-Miguel; Valentina Orlando; Przemyslaw Kardas; Alexandra Prados-Torres
Journal:  Patient Prefer Adherence       Date:  2018-10-05       Impact factor: 2.711

7.  What determines the duration of patient medication compliance in patients with chronic disease: are we looking in the wrong place?

Authors:  Nazli Muzeyyen Sencan; Albert Wertheimer; Chadd Brandon Levine
Journal:  South Med Rev       Date:  2011-12-02

8.  Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study.

Authors:  Monika M Safford; Gaurav Parmar; Codrin S Barasch; Jewell H Halanych; Stephen P Glasser; David C Goff; Ronald J Prineas; Todd M Brown
Journal:  BMC Health Serv Res       Date:  2013-05-01       Impact factor: 2.655

9.  Can differences in medical drug compliance between European countries be explained by social factors: analyses based on data from the European Social Survey, round 2.

Authors:  John Larsen; Henrik Stovring; Jakob Kragstrup; Dorte G Hansen
Journal:  BMC Public Health       Date:  2009-05-16       Impact factor: 3.295

10.  Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports.

Authors:  R Andrew Moore; Sheena Derry; Henry J McQuay
Journal:  Arthritis Res Ther       Date:  2008-05-08       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.